[1] |
ZHANG Jian, FANG Huihua.
Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189.
|
[2] |
GAO Xu, PENG Jin’e, LI Xingwang, ZHANG Wei.
Recent research of antiviral drugs and vaccines for Mpox
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 111-116.
|
[3] |
ZI Wenrui, YANG Qiuyue, SU Jun, XIE Jiang'an.
The research development of inoculation safety associated with licensed HPV vaccines in China
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 311-316.
|
[4] |
LEI Chao, QIAO Meng, CHEN Zijia, ZHANG Qiang, XIE Yanming, WANG Zhifei.
Revision of safety information in instructions of traditional Chinese patent medicines and simple preparations
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(12): 1396-1400.
|
[5] |
WANG Li, YU Wenwen, LI Min, GUO Ruihui, CAO Guangsheng, QI Yingmei.
Risk factors and precautions for adverse drug reactions caused by Digoxin
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1269-1272.
|
[6] |
ZHAO Huanhuan, SONG Jiawei, LIU Jinguang, HUANG Minghui.
One case of nephrotic syndrome caused by rabies vaccine in a 5-year-old child
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1303-1305.
|
[7] |
WU Yunxiao, YU Yuelin, WANG Shengfeng, SUN Feng, MENG Ruogu, ZHAN Siyan.
Suitability assessment of real-world data in active post-marketing surveillance of vaccine safety
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(10): 1081-1089.
|
[8] |
YANG Qiuyue, SU Jun, ZHANG Xue, XIE Jiangan.
Adverse events associated with the three US licensed COVID-19 vaccines based on VAERS database
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(10): 1141-1147.
|
[9] |
ZHOU Pengbo, ZHOU Xiaobing, HUANG Ying, GENG Xingchao.
Research progress in oncolytic drugs
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(1): 7-11.
|
[10] |
SUN Yixin, LIU Zhike, ZHAN Siyan.
Scoping review of near real-time surveillance of vaccine safety
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(1): 61-67.
|
[11] |
FENG Jingnan, ZHAO Houyu, LIU Zhike, ZHAN Siyan.
Self-controlled tree temporal scan statistic in active surveillance of vaccine safety
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(1): 68-73.
|
[12] |
LIU Zhike, ZHAN Siyan.
Progress in applications of self-controlled designs in association study of vaccine safety
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(1): 74-78.
|
[13] |
LIU Yantao, ZHANG Lingli, LIN Yunzhu, CHEN Li, WANG Li.
Mining and research of adverse reaction signals of pneumonia vaccines based on US Vaccine Adverse Event Reporting System
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(1): 96-100.
|
[14] |
PAN Xuejiao, SHEN Lingzhi, LIANG Hui, TANG Xuewen, FU Jian, DING Linling, LYU Huakun.
Incidence and monitoring of AEFI of EV71 vaccine in Zhejiang province
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 897-899.
|
[15] |
WEI Hongtao, SHEN Su, LI Dandan, LIAO Yin.
Pareto chart analysis of 705 problematic prescriptions in neurology
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 900-903.
|